Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mXELOX in metastatic colorectal adenocarcinoma
NCT01552967Phase 2Unknown
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Mar 2012
- Primary completion
- Aug 2013
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, capecitabine in colorectal adenocarcinoma, sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Status: unknown.
02
Drugs
oxaliplatincapecitabine
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT01552967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552967.